205 — BFB Health Cashflow Statement
0.000.00%
- HK$838.31m
- HK$669.63m
- HK$33.12m
Annual cashflow statement for BFB Health, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -43.5 | -87.3 | -40.5 | -29.4 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 52.6 | 122 | 17.7 | 22.5 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -30.4 | -43.3 | -14.6 | 28.1 | — |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -20 | -7.81 | -36.8 | 23 | — |
| Capital Expenditures | -2.85 | -0.014 | 0 | -0.086 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -10.5 | -3.8 | -10.2 | -2.43 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.3 | -3.82 | -10.2 | -2.52 | — |
| Financing Cash Flow Items | -1.83 | 0 | 11.9 | -38.4 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.89 | 72.9 | 4.21 | -43.2 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -32.2 | 57.9 | -42 | -21.5 | — |